Pluripotency is a property shared by certain types of cells that have the ability to differentiate, either spontaneously or following appropriate stimuli, into any of the three germ layers (ectoderm, mesoderm, and endoderm).
post-translational modifications, 17 such as phosphorylation. 18 Here,
we have applied and integrated a multi-'omics' strategy to dissect, at the transcriptional, translational and post-translational level, two distinct human PSCs, the H9 embryonic stem cell line (hESCs), and the induced pluripotent stem cell line (hiPSC-1), obtained by reprogramming of peripheral blood T-lymphocytes from a healthy volunteer. Two additional hiPSC lines, one generated from peripheral blood T-lymphocytes and one generated from skin fibroblasts (hiPSC-2 and hiPSC-3, respectively) were included in this study to validate the proteogenomic data.
| MATERIAL AND ME THODS

| Generation and culture of induced pluripotent stem cells
A written informed consent for human blood and human skin fibroblasts collection was obtained from three healthy donors. The study was approved and supervised by the Ethics Committee of the 'Magna Graecia' University of Catanzaro and the research was carried out according to the World Medical Association Declaration of
Helsinki. hiPSCs were generated from two different cell sources:
T-Lymphocytes isolated from peripheral blood mononuclear cells (PBMCs) (hiPSC-1 and hiPSCs-2 lines) and skin fibroblasts (hiPSCs-3). Fibroblasts were isolated and expanded by the outgrowth method in DMEM containing 10% fetal bovine serum (FBS, Thermo
Fisher Scientific) and 50 U/mL penicillin, and 50 µg/mL streptomycin. Cells were passaged twice before infection for iPSCs gen- For hiPSCs generation from T-lymphocytes, PBMCs were cultured in AIM-V medium (Thermo Fisher Scientific) containing 20% FBS, 50 U/mL penicillin, and 50 µg/mL streptomycin (Thermo Fisher Scientific), supplemented with 125 ng/mL Interleukine-2 (IL-2) (R&D Systems) and finally seeded onto CD3-coated dishes (10 µg/mL, BD Biosciences) for T-lymphocytes activation. 5 × 10 5 T-Lymphocytes were infected with Sendai virus (SeV) 19 at MOI of 20 in feeder-independent conditions. hiPSC lines (hiPSC-1, hiPSC-2, and hiPSC-3) and hESCs H9 (the latter purchased from WiCell Research Institute) were cultured on Matrigel-coated (BD Biosciences) dishes in mTeSR1 medium (STEMCELL Technologies) in a humidified incubator at 37°C at 5% CO 2 . Cells were passaged using Gentle Cell Dissociation Reagent (STEMCELL Technologies). All cell lines were tested for Mycoplasma before being used in experiments.
| Assessment of pluripotency of generated iPSCs
Prior to pluripotency assessment, all generated hiPSCs lines were tested for SeV-transgenes loss by reverse transcription polymerase chain reaction (RT-PCR). Detection of SeV-transgenes was performed in infected parental cells for presence, uninfected parental cells for absence, and generated hiPSCs for loss of viral transgenes.
Pluripotency of generated hiPSCs was assessed for the expression of pluripotency-associated genes (OCT4, NANOG, SOX2, REX1 and DNMT3B) by quantitative real-time PCR (qRT-PCR) and for expression of pluripotency markers (NANOG and OCT4) by immunostaining. Additionally, generated hiPSCs were tested for markers of the three germ layers, NESTIN (ectoderm), BRACHYURY (mesoderm), and SOX17 (endoderm) on whole Embryoid Bodies (EBs) by immunostaining and by qRT-PCR for endoderm (SOX7 and SOX17), mesoderm (HAND1, ACTA2, BMP4), and ectoderm (BMP4 and PAX6)
genes. Moreover, an in-depth gene expression analysis for pluripotency was performed by PluriTest assay. 20 hiPSCs characterization assessment is shown in Figure S1 .
| RNA extraction, RT-PCR and qRT-PCR
Total RNA was extracted using TRIzol reagent (Thermo Fisher Scientific) and 1 µg RNA was used for retro-transcription using the High-capacity cDNA Reverse Transcription Kit (Thermo Fisher Scientific). For SeV detection, half µg of cDNA was used for standard PCR reaction. However, qRT-PCR was used for gene expression quantification using 1 µL of the RT reaction and the Power SYBR Green master Mix (Applied Biosystems). Gene expression levels were normalized to Glyceraldehyde 3-phosphate dehydrogenase (GAPDH) housekeeping gene. qRT-PCR was performed by
StepOnePlus™ Real-time PCR System (Applied Biosystems). A list of primers is provided in Table S1 .
| Immunohistological analysis and alkaline phosphatase staining
Cells were fixed with 4% (vol/vol) paraformaldehyde (PFA) and subjected to immunostaining using the following primary anti- Thermo Fisher Scientific) for 1 hour at 37°C. Nuclei were counterstained using 1 µg/mL Hoechst 33528 (Thermo Fischer Scientific).
Microscopy was performed using imaging systems (DMi8), filter cubes and software from Leica microsystems. AP staining was performed using the 1-Step NBT/BCIP (Thermo Fisher Scientific). 
| Western blotting
For western blot analysis the cells were lysed in RIPA buffer (Sigma- 
| Proteomic and phosphoproteomic analysis: Strategy overview
An integrated strategy that combines enzymatic digestion, isobaric mass tag labelling, a selective affinity technique which uses metal oxide affinity material (MOA) for phosphopeptides enrichment, peptides fractionation by strong cation exchange, and nanoLC coupled with high resolution tandem mass spectrometry was adopted. 
| Microarray procedure
Total RNA was extracted using the Stratagene Absolutely RNA kit and resuspended in RNase-free water. Spectrophotomeric determination of purified RNA yield was performed using the NanoDrop (Thermo Scientific), while total RNA quality was measured using the BioAnalyzer 2100 (Agilent Technologies). Antisense RNA (aRNA) was synthesized, amplified and purified using the Illumina TotalPrep RNA Amplification Kit (Ambion) following the manufacturer's instructions. For microarray, purified aRNA was hybridized to the Human HT-12v4 Expression BeadChip Kit (Illumina). Samples were scanned on the iSCAN system (Illumina). The output file was statistically analysed.
| Statistical analysis
For proteomic data, statistical analysis was carried out by using both were compared by student t-test corrected for multiple hypothesis testing using the Benjamini-Hochberg procedure (q-value <0.05).
22
Protein fold-changes were determined by dividing protein's median fold-changes (n = 4 replicates) of the two data sets. For microarray analysis, primary raw intensity data produced by Illumina iSCAN were imported in R statistical environment using limma package 23 for background subtraction, quantile normalization and log 2 transformation signal values. This procedure also removes the control probes, leaving only the regular ones. Moderated t-test analysis with Benjamini and Hochberg (BH) multiple testing correction were used to identify differentially expressed genes (DEGs) between hESCs and hiPSC-1.
DEGs were selected by a fold-change analysis of ≥1.5 and based on a P value cut-off of ≤0.05. The identified DEGs were annotated in Gene Ontology (GO) and pathway analysis. Ingenuity Pathways Analysis (IPA; Ingenuity Systems, http://www.ingen uity.com website) was used for gene set enrichment and gene network analysis.
| RE SULTS
| Whole proteome identification and classification of DEPs
Proteomics data resulting from nano-Liquid Chromatography
Tandem Mass Spectrometry (nLC-MS/MS) allowed the identification and quantification of 3807 proteins between hiPSC-1 and hESCs samples (Table S4) . For proteomic and phosphoproteomic data, the same statistical cutoff was adapted and 230 statistically significant proteins (q < 0.05) were selected. Interestingly, by comparing hiPSCs vs hESCs, 13 proteins (CRYZ, CES1, SLC2A3, ALB, LBR, HM13, RAB17, SLC3A2, KRI1, RPRD1B, SLC25A1, SLC7A8, SLC6A6) were found enriched, according to a log 2 fold change >0.5, and 25 proteins (PLIN2, IFITM2, PKM, GALNT3, KIAA1524,   SQSTM1, STK26, PSMD5, ACOT9, ALDH16A1, CHCHD2, GMPR2,   PGK1, SLC15A4, TSPAN3, LDHA, IFI30, P4HA2, TSPAN6, TCEAL4, HIST1H4A, HIST1H3A, DHRS4, MT1X, NLRP2) were down-regulated according to the same log 2 fold change (Table 1) . Two proteins, RAB17 and SQSTM1, respectively up-and down-regulated in hiPSC-1 vs hESCs, were selected for biological validation via
Western blot analysis ( Figure 1A ). Although the trend of expression is confirmed for both proteins, only the expression level of SQSTM1 resulted in statistically significant (P value 0.03). RAB17 is a member of the small GTPase superfamily and it has been linked to the down-regulation of cell growth and proliferation. 24 The protein resulted in up-regulated hiPSCs vs hESCs in our proteogenomic com- (Table S6 ) and LBR (Lamin B receptor) (Table S4) , respectively down-and up-regulated in hiPSCs.
| Identification and classification of differentially expressed phosphoproteins
Phosphoproteome analysis allowed us to identify and quantify 5958 phophopeptides and 2623 phosphoproteins (Tables S5 and   S6 HTR1A, PDAP1, SQSTM1, SEMA4B, SPDL1) were found under-expressed in hiPSC-1 samples (based on log 2 hiPSC-1/hESCs <−0.5). Table 2 is relative to differentially expressed phosphoproteins.
Differentially abundant phosphopetides and phosphoproteins, plotted in Figure 2A and 2, account for the enrichment of Gαi Signalling,
Cell Cycle control of chromosomal replication, PCP Pathway, cAMP-mediated Signalling and G-Protein-Coupled receptor Signalling as shown by
IPA analysis in Figure 2C . The expression of two phosphoproteins, the phospho-HSPB1 (Ser82) and the phospho-SQSTM1 (Thr269/Ser272), both down-regulated in hiPSC-1 vs hESCs, was validated via Western
Blot analysis in hESCs and three independent hiPSCs lines (hiPSC-1, hiPSCs-2, and hiPSCs-3), confirming the trend of expression obtained with the phoshoproteomic analysis ( Figure 2D ).
| Transcriptome analysis for the identification and classification of DEGs
Comparative transcriptome analysis of hiPSC-1 vs hESCs, followed by a functional annotation analysis, highlighted 433 DEGs ( Figure 3A) , 136 of which were up-regulated and 297 down-regulated in hiPSC-1 vs hESCs (Table S7) .
IPA analysis uncovered the top canonical pathways enriched in
hiPSC-1 such as Agrin Interactions at Neuromuscular junction, CD28 Signalling in T Helper cells, NRF2-mediated Oxidative stress response, G2/M DNA Damage checkpoint regulation, Protein Ubiquitination pathway, Nur77 Signalling in T Lymphocytes, Germ Cell-Sertoli Cell junction
Signalling, and Calcium-Induced T lymphocytes Apoptosis ( Figure 3B ). 
TA B L E 1 Differentially expressed proteins in hiPSC-1 vs hESCs
| Integrative whole proteome, phosphoproteome and transcriptome analysis
For a comprehensive proteogenomic analysis, we performed a 'cross-omics' study using datasets encompassing mRNA, protein and phosphoprotein expression profiles obtained from hESCs and hiPSC-1. Among the networks commonly shared, we identified the
NRF2-mediated Oxidative Stress Response, Superpathway of Cholesterol
Biosynthesis, and Protein Ubiquitination Pathway. The complete list of signalling pathways identified is provided in Table S8 . Interestingly, Note:: In dark grey phosphoproteins found up-regulated in hiPSCs-1 vs hESCs (based on log 2 hiPSC-1/hESCs >0.5); in light grey phosphoproteins down-regulated in hiPSC-1 vs hESCs (based on log 2 hiPSC-1/hESCs <−0.5).
of embryonic stem cell self-renewal and pluripotency such as NRF, and ERK/MAPK signalling resulted commonly enriched ( Figure 4A ).
Although the majority of pathways identified by this cross-analy- Table S9 .
| Role of the RAR activation pathway and its modulation on the phenotype of human ESCs and human PSCs
Among the pathways identified as differentially regulated in human
ESCs and iPSC-1, we selected the RAR Activation signalling, as retinoids including Vitamin A and its derivatives have been widely associated with embryonic development and differentiation. 27, 28 Here, we evaluated the effects on hESCs and hiPSC-1, -2, and -3 of two molecules, the all-trans Retinoic Acid (RA) which functions as positive regulator of the RAR pathway, and BMS493, a power- formation assay. Even though the overall capability of hESCs and hiPSCs (-1, -2, and 3) to differentiate were maintained, the expression levels of specific germ layer-associated genes such as NESTIN (ectodermal differentiation), BRACHYURY (mesodermal differentiation), and SOX17 (endodermal differentiation) were differentially affected in response to RA, BMS or both used in combination. While the differentiation ability of hESCs was not significantly affected by the treatment with RA or BMS493 or both in combination as shown by immunofluorescence quantification, the hiPSCs lines (-1, -2, and -3) showed an enhanced expression of SOX17 when they were simultaneously exposed to RA and BMS493 (RA+/BMS493+) as shown by immunofluorescence ( Figure S3 ) and its quantification ( Figure 5C ).
qRT-PCR analysis for NESTIN, MESP1 and SOX17 expression showed a reduction of these markers in hESCs in all the three conditions tested (RA+; BMS493+; RA+/BMS493+); conversely, although the hiPSC lines showed a similar trend when exposed either to RA or BMS493, they completely recovered their endodermal and mesodermal differentiation potential when simultaneously treated with F I G U R E 3 A, Volcano plot representing differentially expressed genes (blue dots) between hiPSC-1 and hESCs; the unchanged genes are shown as red dots. The x-axis specifies the Log 2 fold change (Fc) and the y-axis specifies the q-value negative logarithm in base 10. B, Top canonical signalling pathways uncovered by Ingenuity Pathway Analysis. C, Heat Map representing color-coded networks derived from the integrative transcriptomic, whole proteomic and phosphoproteomic analysis of hiPSC-1 and hESCs (the colour intensity scale is proportional to the statistical significance of a specific pathway enriched in each dataset, -log (P-value). D, Quantitative real-time polymerase chain reaction analysis of the NRF2-mediated Oxidative Stress Response (AKR1C3, GST, CAT), Sonic Hedgehog (DYRK1A and GLI2) and Protein Ubiquitination pathways (PSMC4 and MYSM1) -associated genes. Expression values are normalized to GAPDH and relative to hESCs. Data are mean ± SD from three independent experiments (*P < 0.05, ***P < 0.001, t-test). hESCs, human embryonic stem cells; hiPSCs, human induced pluripotent stem cells both molecules (RA+/BMS493+), while the ectodermal differentiation capability did not significantly changed ( Figure 5D ).
| D ISCUSS I ON
Recent breakthroughs in stem cells research allowed to envision a scenario in which a stem cell-based therapy might become reality.
Particularly, the findings that differentiated somatic cells can be reprogrammed back to a pluripotent state and subsequently differentiated towards several cell types showed the feasibility of using the hiPSCs in a clinical setting. Although hiPSCs share a number of characteristics with hESCs, many fundamental questions around their molecular and functional equivalence still remain unanswered. Here we used a combined multi -"omics" strategy for proteogenomic analysis of hESCs and hiPSC, highlighting differences between these cells. IPA analysis of DEPs and transcripts demonstrated the enrichment of signalling pathways mostly associated to pluripotency and cellular metabolism, whose role goes beyond energy production being crucial in cell fate regulation. 31 The HIF1α signalling, for instance, enriched in hiPSC-1 vs hESCs, mediates the effects of oxygen concentration on stem cells proliferation and differentiation by induction of the hypoxia-associated genes. 32 Accordingly, in response to oxygen fluctuations, oxygen signalling controls the balance between pluripotency and differentiation. Highly pluripotent ESCs associate with hypoxia, high levels of glucose consumption and large amount of lactate production. 33, 34 The NRF2-mediated oxidative stress response pathway, commonly enriched in hESCs and hiPSC-1, has been described as a key regulator of self-renewal ability of hESCs playing a role in re-establishment of pluripotency during cellular reprogramming. 35, 36 Although PSCs rely more on glycolysis for energy and rapid cell proliferation, the tricarboxylic acid cycle in PSCs provides intermediate metabolites such a citrate and α-ketoglutarate that are siphoned for lipids and amino acid biosynthesis. 37 We found that LDHA and two glycolytic enzymes, phosphoglycerate kinase 1 (PGK1) and the pyruvate kinase (PKM) are down regulated in hiPSC-1 compared to hESCs, while the mi- BMS493, supporting the fact that a synergistic action of both molecules is sufficient to restore the activity of the pathway.
In conclusion, our data indicate that the molecular correspondence between hiPSCs and hESCs is not exactly linear, as demon- 
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